Green Queen

GEA Pumps $4.6M to Build Out New Alternative Protein Centre in Germany

German engineering company GEA is relocating its Application and Technology Center for future food from Hildesheim to ...
Newspoint on MSN

JMI admission: Applications for biotechnology PG admission start tomorrow; GAT-B score mandatory

JMI Admission 2026: Jamia Millia Islamia has announced the admission process for the M.Sc. Biotechnology program for the 2026 ...
vegconomist

GEA Invests €4M in New Technology Center for Scaling Biotech and New Food Processes

GEA has moved its Application and Technology Center (ATC) for New Food and biotechnology from Hildesheim to Sarstedt in Lower Saxony, Germany, investing €4 ...
MoneyWeekOpinion

Dr Douglas Williams: new drugs and AI will fuel the biotech boom

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

VERAXA Biotech (NASDAQ: VRXA) Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...
Fierce Biotech

FDA halts release of new drug rejection letters while working to formalize policy

The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, Fierce Biotech ...

AI system translates protein sequences into text, helping reveal functions of unknown proteins

In a paper published in Proceedings of the National Academy of Sciences, researchers from Technion and Tel Aviv University ...

Light flips bacterial signaling enzyme between two shapes, unlocking how signals travel

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

Pro-Trump 'Biohacker' Reveals Autoimmune Disease Diagnosis: 'My Stomach Is Eating Itself'

Bryan Johnson, a 48-year-old biotech entrepreneur determined to live "multiple lifetimes" with his teenage son, shared the ...

Candel Therapeutics: An Overlooked Late-Stage Biotech With Real Potential

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
The Manila Times

Sapu Nano Successfully Completes Initial Safety Cohort of Phase 1b SP-03-B101 Trial; Independent Safety Review Committee Recommends Dose Escalation and European Expansion Underway

SAN DIEGO, US - Media OutReach Newswire - 9 July 2026 - Sapu Nano (US) LLC, a clinical-stage biotechnology company developing the proprietary Deciparticle™ nanomedicine platform, today announced that ...